Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnoCare OptoelectronicsTPE:6861 -0.26%74 EV-to-EBIT is 21.85 as of Aug. 30, 2026, which is 40% above its 10-year median of 15.57. GuruFocus rates TPE:6861 with a GF Score™ of 74/100 and a GF Value™ of NT$101.46 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 477 Medical Devices & Instruments companies, InnoCare Optoelectronics ranks worse than 57.86% on this metric.
The historical rank and industry rank for InnoCare Optoelectronics's EV-to-EBIT or its related term are showing as below:
TPE:6861'
s EV-to-EBIT Range Over the Past 10 Years
Min: 5.62 Med: 15.57 Max: 72.55
Current: 21.85
During the past 8 years, the highest EV-to-EBIT of InnoCare Optoelectronics was 72.55. The lowest was 5.62. And the median was 15.57.
TPE:6861's EV-to-EBIT is ranked worse than 57.86% of 477
companies
in the Medical Devices & Instruments industry
Industry Median: 18.99
vs TPE:6861: 21.85
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
InnoCare Optoelectronics's Enterprise Value for the quarter that ended in Jun. 2026 was NT$13,093 Mil.
InnoCare Optoelectronics's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$334 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCare Optoelectronics EV-to-EBIT Related Terms
InnoCare Optoelectronics EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InnoCare Optoelectronics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's EV-to-EBIT falls into.
InnoCare Optoelectronics's current Enterprise Value is NT$7,290 Mil.
InnoCare Optoelectronics's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$334 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCare Optoelectronics (TPE:6861) has a EV-to-EBIT of 21.85 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on InnoCare Optoelectronics and its competitors. This is 40% above median its historical median of 15.57. Over the past decade, InnoCare Optoelectronics' EV-to-EBIT has ranged from 5.62 to 72.55. According to the industry distribution chart, InnoCare Optoelectronics ranks #276 out of 477 companies in the Medical Devices & Instruments industry, placing it in the top 57.9%.
Is InnoCare Optoelectronics' EV-to-EBIT too high?
InnoCare Optoelectronics' current EV-to-EBIT of 21.85 is 40% above median its 10-year median of 15.57. Over the past 10 years, this metric has ranged from a low of 5.62 to a high of 72.55. The Medical Devices & Instruments industry median EV-to-EBIT is 18.99. InnoCare Optoelectronics' value of 21.85 is 15.1% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #276 out of 477 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, InnoCare Optoelectronics has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #276 out of 477 companies for EV-to-EBIT. This places InnoCare Optoelectronics in the lower half of its industry. The industry median EV-to-EBIT is 18.99. InnoCare Optoelectronics' value of 21.85 is 15.1% above this benchmark. Historically, InnoCare Optoelectronics' own EV-to-EBIT has ranged from 5.62 to 72.55 over the past decade. While the company's 10-year median is 15.57 vs. the industry median of 18.99, InnoCare Optoelectronics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.99, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current EV-to-EBIT of 21.85 is 15.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on InnoCare Optoelectronics and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current EV-to-EBIT is 21.85, which is 40% above median its own 10-year median of 15.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$101.46, compared to a current price of NT$193.50 — trading 90.7% above its estimated fair value. The current EV-to-EBIT is 21.85, which is 40% above median its 10-year median of 15.57 and 15.1% above the Medical Devices & Instruments industry median of 18.99. InnoCare Optoelectronics' overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current EV-to-EBIT is 21.85 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$193.50 is trading 90.7% above its estimated GF Value™ of NT$101.46.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
EV-to-EBIT: 21.85 (40% above median its 10-year median of 15.57)
GF Value™: NT$101.46 vs. price of NT$193.50 (90.7% above fair value)
Industry Position: 15.1% above the Medical Devices & Instruments median (#276 of 477)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
74GF Score
Get the complete analysis for TPE:6861
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
